169 related articles for article (PubMed ID: 37922013)
1. Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.
Drenthen LCA; de Baaij JHF; Rodwell L; van Herwaarden AE; Tack CJ; de Galan BE
Diabetologia; 2024 Jan; 67(1):52-61. PubMed ID: 37922013
[TBL] [Abstract][Full Text] [Related]
2. Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial.
Andriessen C; Fealy CE; Veelen A; van Beek SMM; Roumans KHM; Connell NJ; Mevenkamp J; Moonen-Kornips E; Havekes B; Schrauwen-Hinderling VB; Hoeks J; Schrauwen P
Diabetologia; 2022 Oct; 65(10):1710-1720. PubMed ID: 35871650
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
Pieber TR; Arfelt KN; Cailleteau R; Hart M; Kar S; Mursic I; Svehlikova E; Urschitz M; Haahr H
Diabetologia; 2023 Aug; 66(8):1413-1430. PubMed ID: 37308751
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
5. Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT).
Honsek C; Kabisch S; Kemper M; Gerbracht C; Arafat AM; Birkenfeld AL; Dambeck U; Osterhoff MA; Weickert MO; Pfeiffer AFH
Diabetologia; 2018 Jun; 61(6):1295-1305. PubMed ID: 29492637
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
[TBL] [Abstract][Full Text] [Related]
9. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
Rosenstock J; Frias J; Jastreboff AM; Du Y; Lou J; Gurbuz S; Thomas MK; Hartman ML; Haupt A; Milicevic Z; Coskun T
Lancet; 2023 Aug; 402(10401):529-544. PubMed ID: 37385280
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
[TBL] [Abstract][Full Text] [Related]
11. Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.
Karamali M; Bahramimoghadam S; Sharifzadeh F; Asemi Z
Appl Physiol Nutr Metab; 2018 Jun; 43(6):565-570. PubMed ID: 29316405
[TBL] [Abstract][Full Text] [Related]
12. A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial.
Monteyne AJ; Falkenhain K; Whelehan G; Neudorf H; Abdelrahman DR; Murton AJ; Wall BT; Stephens FB; Little JP
Diabetologia; 2024 Jun; 67(6):1107-1113. PubMed ID: 38483543
[TBL] [Abstract][Full Text] [Related]
13. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
14. Glucose effectiveness, but not insulin sensitivity, is improved after short-term interval training in individuals with type 2 diabetes mellitus: a controlled, randomised, crossover trial.
Karstoft K; Clark MA; Jakobsen I; Knudsen SH; van Hall G; Pedersen BK; Solomon TPJ
Diabetologia; 2017 Dec; 60(12):2432-2442. PubMed ID: 28842722
[TBL] [Abstract][Full Text] [Related]
15. Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.
Nilsson M; Jensen N; Gejl M; Bergmann ML; Storgaard H; Zander M; Miskowiak K; Rungby J
Diabetologia; 2019 Oct; 62(10):1948-1958. PubMed ID: 31367958
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study.
Frias J; Chien J; Zhang Q; Chigutsa E; Landschulz W; Syring K; Wullenweber P; Haupt A; Kazda C
Lancet Diabetes Endocrinol; 2023 Mar; 11(3):158-168. PubMed ID: 36758572
[TBL] [Abstract][Full Text] [Related]
18. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients.
de Valk HW; Verkaaik R; van Rijn HJ; Geerdink RA; Struyvenberg A
Diabet Med; 1998 Jun; 15(6):503-7. PubMed ID: 9632126
[TBL] [Abstract][Full Text] [Related]
19. Effects of magnesium supplementation on carotid intima-media thickness and metabolic profiles in diabetic haemodialysis patients: a randomised, double-blind, placebo-controlled trial.
Talari HR; Zakizade M; Soleimani A; Bahmani F; Ghaderi A; Mirhosseini N; Eslahi M; Babadi M; Mansournia MA; Asemi Z
Br J Nutr; 2019 Apr; 121(7):809-817. PubMed ID: 30739626
[TBL] [Abstract][Full Text] [Related]
20. The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
Heimbürger SMN; Hoe B; Nielsen CN; Bergmann NC; Hartmann B; Holst JJ; Vilsbøll T; Dejgaard TF; Christensen MB; Knop FK
Diabetologia; 2021 Nov; 64(11):2425-2431. PubMed ID: 34405256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
